David Ahlquist Tag

[caption id="attachment_17713" align="alignright" width="227"] Exact Sciences CEO Kevin Conroy[/caption] Cancer is detected too late. Today, a staggering 70% of incident cancers have no routine early detection tests. As a result, most patients are diagnosed after they develop signs and symptoms of their disease. These “symptom-detected” cancers...

Madison cancer diagnostics company Exact Sciences Corp. is working on a test that would screen for multiple types of cancer with a single blood draw. It’s aiming to help people catch early-stage cancer so it can be treated quickly. The test passed proof of concept in a 10,000-person...